| UniProt ID | E4F1_HUMAN | |
|---|---|---|
| UniProt AC | Q66K89 | |
| Protein Name | Transcription factor E4F1 | |
| Gene Name | E4F1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 784 | |
| Subcellular Localization | Nucleus, nucleoplasm. Cytoplasm. A small fraction is detected in the cytoplasm. Excluded from the nucleolus where it is targeted upon CDKN2A overexpression. Localizes to the mitotic spindle during embryogenesis.. | |
| Protein Description | May function as a transcriptional repressor. May also function as a ubiquitin ligase mediating ubiquitination of chromatin-associated TP53. Functions in cell survival and proliferation through control of the cell cycle. Functions in the p53 and pRB tumor suppressor pathways and regulates the cyclin CCNA2 transcription.; Identified as a cellular target of the adenoviral oncoprotein E1A, it is required for both transcriptional activation and repression of viral genes.. | |
| Protein Sequence | MEGAMAVRVTAAHTAEAQAEAGREAGEGAVAAVAAALAPSGFLGLPAPFSEEDEDDVHRCGRCQAEFTALEDFVQHKIQKACQRAPPEALPATPATTALLGQEVVPAAPGPEEPITVAHIVVEAASLAADISHASDLVGGGHIKEVIVAAEAELGDGEMAEAPGSPRQQGLGLAGEGEQAQVKLLVNKDGRYVCALCHKTFKTGSILKAHMVTHSSRKDHECKLCGASFRTKGSLIRHHRRHTDERPYKCSKCGKSFRESGALTRHLKSLTPCTEKIRFSVSKDVVVSKEDARAGSGAGAAGLGTATSSVTGEPIETSPVIHLVTDAKGTVIHEVHVQMQELSLGMKALAPEPPVSQELPCSSEGSRENLLHQAMQNSGIVLERAAGEEGALEPAPAAGSSPQPLAVAAPQLPVLEVQPLETQVASEASAVPRTHPCPQCSETFPTAATLEAHKRGHTGPRPFACAQCGKAFPKAYLLKKHQEVHVRERRFRCGDCGKLYKTIAHVRGHRRVHSDERPYPCPKCGKRYKTKNAQQVHFRTHLEEKPHVCQFCSRGFREKGSLVRHVRHHTGEKPFKCYKCGRGFAEHGTLNRHLRTKGGCLLEVEELLVSEDSPAAATTVLTEDPHTVLVEFSSVVADTQEYIIEATADDAETSEATEIIEGTQTEVDSHIMKVVQQIVHQASAGHQIIVQNVTMDEETALGPEAAAADTITIATPESLTEQVAMTLASAISEGTVLAARAGTSGTEQATVTMVSSEDIEILEHAGELVIASPEGQLEVQTVIV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 50 | Phosphorylation | LGLPAPFSEEDEDDV CCCCCCCCCCCCCCC | 38.73 | 25159151 | |
| 165 | Phosphorylation | EMAEAPGSPRQQGLG CCCCCCCCCCCCCCC | 18.82 | 20860994 | |
| 188 | Ubiquitination | QVKLLVNKDGRYVCA EEEEEECCCCCEEEE | 54.82 | - | |
| 202 | Sumoylation | ALCHKTFKTGSILKA EEECCEECCCCHHHE | 58.15 | - | |
| 202 | Sumoylation | ALCHKTFKTGSILKA EEECCEECCCCHHHE | 58.15 | - | |
| 205 | Phosphorylation | HKTFKTGSILKAHMV CCEECCCCHHHEEEE | 29.94 | 24719451 | |
| 213 | Phosphorylation | ILKAHMVTHSSRKDH HHHEEEECCCCCCCC | 14.41 | 27732954 | |
| 215 | Phosphorylation | KAHMVTHSSRKDHEC HEEEECCCCCCCCCC | 23.60 | 20068231 | |
| 216 | Phosphorylation | AHMVTHSSRKDHECK EEEECCCCCCCCCCC | 35.43 | 27732954 | |
| 223 | Sumoylation | SRKDHECKLCGASFR CCCCCCCCCCCCEEC | 43.77 | - | |
| 223 | Sumoylation | SRKDHECKLCGASFR CCCCCCCCCCCCEEC | 43.77 | - | |
| 243 | Phosphorylation | IRHHRRHTDERPYKC HHHCCCCCCCCCCCC | 37.43 | 24719451 | |
| 251 | Phosphorylation | DERPYKCSKCGKSFR CCCCCCCCCCCCCHH | 27.16 | - | |
| 256 | Phosphorylation | KCSKCGKSFRESGAL CCCCCCCCHHHCCHH | 18.15 | 24719451 | |
| 260 | Phosphorylation | CGKSFRESGALTRHL CCCCHHHCCHHHHHH | 25.72 | 25159151 | |
| 268 | Ubiquitination | GALTRHLKSLTPCTE CHHHHHHHHCCCCCC | 36.98 | 29967540 | |
| 269 | Phosphorylation | ALTRHLKSLTPCTEK HHHHHHHHCCCCCCE | 43.78 | 27251275 | |
| 289 | Ubiquitination | SKDVVVSKEDARAGS CCCEEEEHHHHCCCC | 48.26 | - | |
| 289 | Sumoylation | SKDVVVSKEDARAGS CCCEEEEHHHHCCCC | 48.26 | - | |
| 289 | Sumoylation | SKDVVVSKEDARAGS CCCEEEEHHHHCCCC | 48.26 | - | |
| 296 | Phosphorylation | KEDARAGSGAGAAGL HHHHCCCCCCCCCCC | 25.20 | 28122231 | |
| 307 | Phosphorylation | AAGLGTATSSVTGEP CCCCCCCCCCCCCCC | 22.75 | 28122231 | |
| 308 | Phosphorylation | AGLGTATSSVTGEPI CCCCCCCCCCCCCCC | 21.98 | 28122231 | |
| 309 | Phosphorylation | GLGTATSSVTGEPIE CCCCCCCCCCCCCCC | 21.24 | 28122231 | |
| 311 | Phosphorylation | GTATSSVTGEPIETS CCCCCCCCCCCCCCC | 37.46 | 28122231 | |
| 317 | Phosphorylation | VTGEPIETSPVIHLV CCCCCCCCCCEEEEE | 38.76 | 18669648 | |
| 318 | Phosphorylation | TGEPIETSPVIHLVT CCCCCCCCCEEEEEE | 12.36 | 29496963 | |
| 325 | Phosphorylation | SPVIHLVTDAKGTVI CCEEEEEECCCCCEE | 36.28 | 21712546 | |
| 396 | Ubiquitination | EGALEPAPAAGSSPQ CCCCCCCCCCCCCCC | 33.10 | 29967540 | |
| 400 | Phosphorylation | EPAPAAGSSPQPLAV CCCCCCCCCCCCCEE | 33.83 | 26074081 | |
| 401 | Phosphorylation | PAPAAGSSPQPLAVA CCCCCCCCCCCCEEE | 27.00 | 29496963 | |
| 458 | Phosphorylation | EAHKRGHTGPRPFAC HHHHCCCCCCCCCEE | 52.27 | 25159151 | |
| 501 | Ubiquitination | GDCGKLYKTIAHVRG CCHHHHHHHHHHHCC | 43.84 | - | |
| 514 | Phosphorylation | RGHRRVHSDERPYPC CCCCCCCCCCCCCCC | 38.01 | 27732954 | |
| 519 | Phosphorylation | VHSDERPYPCPKCGK CCCCCCCCCCCCCCC | 24.56 | 27732954 | |
| 545 | Ubiquitination | FRTHLEEKPHVCQFC EEHHHCCCCCHHHHC | 30.92 | - | |
| 545 | Sumoylation | FRTHLEEKPHVCQFC EEHHHCCCCCHHHHC | 30.92 | - | |
| 545 | Sumoylation | FRTHLEEKPHVCQFC EEHHHCCCCCHHHHC | 30.92 | - | |
| 559 | Sumoylation | CSRGFREKGSLVRHV CCCCHHHCCCHHHHH | 49.93 | - | |
| 559 | Sumoylation | CSRGFREKGSLVRHV CCCCHHHCCCHHHHH | 49.93 | - | |
| 570 | Phosphorylation | VRHVRHHTGEKPFKC HHHHCCCCCCCCCCE | 40.69 | - | |
| 573 | Ubiquitination | VRHHTGEKPFKCYKC HCCCCCCCCCCEEEC | 58.04 | 29967540 | |
| 589 | Phosphorylation | RGFAEHGTLNRHLRT CCCHHHCCHHHHHHC | 23.83 | - | |
| 613 | Phosphorylation | ELLVSEDSPAAATTV EEEECCCCCCCEEEE | 16.64 | 24275569 | |
| 627 | Phosphorylation | VLTEDPHTVLVEFSS EECCCCCEEEEEEEE | 22.41 | 22468782 | |
| 653 | Phosphorylation | ATADDAETSEATEII EECCCCCCCCCCHHH | 33.32 | 29759185 | |
| 654 | Phosphorylation | TADDAETSEATEIIE ECCCCCCCCCCHHHC | 19.42 | 29759185 | |
| 657 | Phosphorylation | DAETSEATEIIEGTQ CCCCCCCCHHHCCCH | 24.54 | 29759185 | |
| 772 | Phosphorylation | AGELVIASPEGQLEV CCEEEEECCCCCEEE | 16.62 | 26074081 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of E4F1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of E4F1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of E4F1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50, AND MASSSPECTROMETRY. | |